- Home
- RAPP vs IIIV Comparison
RAPP vs IIIV Comparison
Compare RAPP & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPP
- IIIV
- Stock Information
- Founded
- RAPP 2022
- IIIV 2012
- Country
- RAPP United States
- IIIV United States
- Employees
- RAPP N/A
- IIIV N/A
- Industry
- RAPP
- IIIV EDP Services
- Sector
- RAPP
- IIIV Technology
- Exchange
- RAPP Nasdaq
- IIIV Nasdaq
- Market Cap
- RAPP 508.4M
- IIIV 570.8M
- IPO Year
- RAPP 2024
- IIIV 2018
- Fundamental
- Price
- RAPP $14.43
- IIIV $25.55
- Analyst Decision
- RAPP Strong Buy
- IIIV Buy
- Analyst Count
- RAPP 4
- IIIV 7
- Target Price
- RAPP $37.33
- IIIV $27.14
- AVG Volume (30 Days)
- RAPP 94.6K
- IIIV 281.3K
- Earning Date
- RAPP 02-10-2025
- IIIV 02-06-2025
- Dividend Yield
- RAPP N/A
- IIIV N/A
- EPS Growth
- RAPP N/A
- IIIV N/A
- EPS
- RAPP N/A
- IIIV 4.84
- Revenue
- RAPP N/A
- IIIV $229,923,000.00
- Revenue This Year
- RAPP N/A
- IIIV $11.47
- Revenue Next Year
- RAPP N/A
- IIIV $8.50
- P/E Ratio
- RAPP N/A
- IIIV $5.28
- Revenue Growth
- RAPP N/A
- IIIV 1.41
- 52 Week Low
- RAPP $12.10
- IIIV $17.54
- 52 Week High
- RAPP $29.74
- IIIV $26.66
- Technical
- Relative Strength Index (RSI)
- RAPP N/A
- IIIV 67.21
- Support Level
- RAPP N/A
- IIIV $23.49
- Resistance Level
- RAPP N/A
- IIIV $24.61
- Average True Range (ATR)
- RAPP 0.00
- IIIV 0.66
- MACD
- RAPP 0.00
- IIIV 0.18
- Stochastic Oscillator
- RAPP 0.00
- IIIV 98.85
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
About IIIV i3 Verticals Inc.
i3 Verticals Inc offers integrated payment and software solutions to small and medium-sized businesses and organizations in strategic vertical markets. Its operating segment includes Public Sector and Healthcare. The company generates maximum revenue from the Public Sector segment.